Esprinet Spa (IT:PRT)
:PRT
Want to see IT:PRT full AI Analyst Report?
Top Page
Esprinet Spa
(PRT)
Select Model
Select Model
Rating:68Neutral
Price Target:
€7.50
▲(26.05% Upside)
Action:Reiterated
Date:05/21/26
The score is led by strong valuation (low P/E and ~5.19% yield) and supportive technical momentum (price above key moving averages with positive MACD). These positives are tempered by mid-level financial performance due to very thin margins, increased leverage, and volatile/declining free cash flow.
Positive Factors
Profitability recovery & modest revenue growth
Esprinet's return to positive net income and modest TTM revenue growth indicate the company has stabilized after recent volatility. For a low‑margin distributor, consistent profitability and even small top‑line gains support reinvestment in logistics, vendor terms, and resilience across business cycles over the next several months.
Negative Factors
Structurally thin margins
Margins under 2% leave limited buffer for cost inflation, vendor price pressure, or volume declines. In a distribution model where gross margin drives economics, such compressed profitability makes long‑term earnings sensitive to small cost or pricing shifts and reduces ability to absorb adverse shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability recovery & modest revenue growth
Esprinet's return to positive net income and modest TTM revenue growth indicate the company has stabilized after recent volatility. For a low‑margin distributor, consistent profitability and even small top‑line gains support reinvestment in logistics, vendor terms, and resilience across business cycles over the next several months.
Read all positive factors
Esprinet Spa (PRT) vs. iShares MSCI Italy ETF (EWI)
Market Cap
€327.56M
Dividend Yield6.66%
Average Volume (3M)377.06K
Price to Earnings (P/E)15.3
Beta (1Y)1.00
Revenue Growth5.19%
EPS Growth19.63%
CountryIT
Employees1,808
SectorGeneral
Sector StrengthN/A
IndustryTechnology Distributors
Share Statistics
EPS (TTM)0.46
Shares Outstanding50,417,416
10 Day Avg. Volume193,273
30 Day Avg. Volume377,057
Financial Highlights & Ratios
PEG Ratio-2.21
Price to Book (P/B)0.78
Price to Sales (P/S)0.07
P/FCF Ratio6.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.57Price Target Upside27.17% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.54
Revenue Forecast (FY)€4.49B
Esprinet Spa Business Overview & Revenue Model
Company Description
Esprinet S.p.A., together with its subsidiaries, engages in the wholesale distribution of information technology (IT) and consumer electronics primarily in Italy, Spain, Portugal, and rest of Europe. The company distributes home, leisure, and offi...
How the Company Makes Money
Esprinet makes money primarily by purchasing technology and consumer-electronics products from vendors/manufacturers and reselling them to business customers in the distribution channel (e.g., resellers, retailers, e-commerce players, and system i...
Esprinet Spa Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
52
Neutral
Cash Flow
44
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.39B | 4.29B | 4.14B | 3.99B | 4.68B | 4.69B |
| Gross Profit | 240.31M | 235.07M | 226.94M | 218.44M | 242.97M | 231.89M |
| EBITDA | 71.82M | 71.37M | 68.82M | 35.82M | 86.93M | 83.05M |
| Net Income | 22.51M | 20.17M | 21.52M | -11.88M | 47.35M | 44.18M |
Balance Sheet | ||||||
| Total Assets | 1.91B | 2.08B | 2.02B | 1.84B | 1.87B | 1.92B |
| Cash, Cash Equivalents and Short-Term Investments | 154.36M | 230.78M | 216.35M | 261.00M | 172.19M | 491.47M |
| Total Debt | 511.08M | 278.00M | 262.28M | 249.00M | 265.68M | 273.81M |
| Total Liabilities | 1.51B | 1.69B | 1.63B | 1.47B | 1.47B | 1.54B |
| Stockholders Equity | 392.41M | 389.47M | 389.25M | 367.41M | 409.22M | 386.12M |
Cash Flow | ||||||
| Free Cash Flow | 31.05M | 45.98M | -3.20M | 154.55M | -263.84M | 15.81M |
| Operating Cash Flow | 35.41M | 49.32M | 2.77M | 168.04M | -251.41M | 21.65M |
| Investing Cash Flow | -25.69M | -24.55M | -5.61M | -19.95M | -19.06M | -17.02M |
| Financing Cash Flow | -66.95M | -10.46M | -41.80M | -59.39M | -48.82M | -72.09M |
Esprinet Spa Technical Analysis
Positive
5.95
Price Trends
5.55
Positive
5.60
Positive
5.43
Positive
Market Momentum
0.32
Positive
61.01
Neutral
21.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:PRT, the sentiment is Positive. The current price of 5.95 is below the 20-day moving average (MA) of 6.40, above the 50-day MA of 5.55, and above the 200-day MA of 5.43, indicating a bullish trend. The MACD of 0.32 indicates Positive momentum. The RSI at 61.01 is Neutral, neither overbought nor oversold. The STOCH value of 21.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IT:PRT.
Esprinet Spa Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | €5.29B | 13.62 | 16.56% | 2.24% | 8.71% | 1.84% | |
68 Neutral | €327.56M | 15.30 | 5.62% | 6.66% | 5.19% | 19.63% | |
62 Neutral | €126.34M | 12.62 | 20.78% | 6.60% | -4.12% | -46.09% | |
62 Neutral | €1.44B | 22.09 | 15.29% | 1.15% | 9.35% | 4.41% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
47 Neutral | €63.72M | -7.15 | -51.98% | ― | 4.21% | 83.28% |
* General Sector Average
IT:PRT
Esprinet Spa
6.97
3.34
92.40%
IT:BEC
B&C Speakers S.p.A.
11.40
-4.25
-27.16%
IT:EPH
ePRICE S.p.A.
0.08
-0.03
-29.09%
IT:DLG
De'Longhi S.p.A.
35.68
8.28
30.20%
IT:ETH
Eurotech S.p.A.
1.07
0.28
36.22%
IT:SES
Sesa S.p.A.
97.05
17.40
21.85%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.